Total Payments
$80,305
2024 Payments
$10,784
Companies
31
Transactions
1,081
Medicare Patients
215
Medicare Billing
$59,191
Payment Breakdown by Category
Other$60,440 (75.3%)
Food & Beverage$17,682 (22.0%)
Travel$1,807 (2.2%)
Education$376.51 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,440 | 33 | 75.3% |
| Food and Beverage | $17,682 | 1,030 | 22.0% |
| Travel and Lodging | $1,807 | 9 | 2.2% |
| Education | $376.51 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $41,003 | 105 | $0 (2024) |
| Allergan, Inc. | $26,155 | 90 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $3,354 | 244 | $0 (2024) |
| Alkermes, Inc. | $2,186 | 147 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,097 | 133 | $0 (2024) |
| ITI, Inc. | $1,087 | 65 | $0 (2023) |
| Lundbeck LLC | $773.04 | 50 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $527.48 | 38 | $0 (2018) |
| Neos Therapeutics, LP | $517.59 | 52 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $479.14 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,784 | 133 | ABBVIE INC. ($8,742) |
| 2023 | $17,533 | 128 | AbbVie Inc. ($16,070) |
| 2022 | $9,479 | 160 | ABBVIE INC. ($7,303) |
| 2021 | $11,360 | 126 | AbbVie Inc. ($8,887) |
| 2020 | $8,572 | 86 | Allergan, Inc. ($7,606) |
| 2019 | $8,724 | 153 | Allergan Inc. ($7,148) |
| 2018 | $7,414 | 148 | Allergan Inc. ($5,558) |
| 2017 | $6,439 | 147 | Allergan Inc. ($4,523) |
All Payment Transactions
1,081 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CNS | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: CNS | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Central Nervous System | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: ADHD | ||||||
| 11/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CNS | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Central Nervous System | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 231 | $49,700 | $16,461 |
| 2022 | 3 | 44 | 176 | $38,400 | $12,189 |
| 2021 | 4 | 58 | 137 | $41,100 | $10,220 |
| 2020 | 3 | 73 | 313 | $93,900 | $20,321 |
Total Patients
215
Total Services
857
Medicare Billing
$59,191
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 116 | $24,950 | $8,312 | 33.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 20 | 115 | $24,750 | $8,149 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 88 | $19,200 | $6,358 | 33.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 14 | 56 | $11,500 | $4,265 | 37.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 13 | 32 | $7,700 | $1,566 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 33 | $9,900 | $3,621 | 36.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 52 | $15,600 | $3,478 | 22.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 16 | 31 | $9,300 | $1,950 | 21.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 12 | 21 | $6,300 | $1,172 | 18.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 156 | $46,800 | $9,818 | 21.0% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 24 | 111 | $33,300 | $7,900 | 23.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 21 | 46 | $13,800 | $2,603 | 18.9% |
About Dr. Wei Wang, M.D
Dr. Wei Wang, M.D is a Psychiatry healthcare provider based in Tenafly, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902813876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Wang, M.D has received a total of $80,305 in payments from pharmaceutical and medical device companies, with $10,784 received in 2024. These payments were reported across 1,081 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,440).
As a Medicare-enrolled provider, Wang has provided services to 215 Medicare beneficiaries, totaling 857 services with total Medicare billing of $59,191. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Tenafly, NJ
- Active Since 08/02/2006
- Last Updated 05/02/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902813876
Products in Payments
- VRAYLAR (Drug) $67,044
- ABILIFY MAINTENA (Drug) $1,884
- ARISTADA (Drug) $1,786
- REXULTI (Drug) $1,751
- CAPLYTA (Drug) $1,566
- AUSTEDO (Drug) $1,435
- LATUDA (Drug) $527.48
- Adzenys XR-ODT (Drug) $506.35
- Aristada 441 mg (Drug) $327.61
- APLENZIN (Drug) $257.14
- Austedo XR (Drug) $251.27
- ABILIFY ASIMTUFII (Drug) $241.86
- INVEGA TRINZA (Drug) $216.90
- NUEDEXTA (Drug) $161.58
- INVEGA SUSTENNA (Drug) $153.27
- Horizant (Drug) $139.51
- Trintellix (Drug) $138.53
- Evekeo (Drug) $99.30
- BRINTELLIX (Drug) $96.75
- BrainsWay Deep TMS (Device) $96.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tenafly
Dr. Vinod Suresh, M.d, M.D
Psychiatry — Payments: $274.98
Psychiatry $274.98
Dr. Arturo Archila, Md, MD
Psychiatry — Payments: $267.40
Psychiatry $267.40
Dr. Samar Abrar, Md, MD
Psychiatry — Payments: $43.33
Psychiatry $43.33
Dinohra Munoz-Silva, Md, MD
Psychiatry — Payments: $13.50
Psychiatry $13.50
Jay Friedman, Md, MD
Psychiatry
Psychiatry
Dr. Natalya Knafel, M.d, M.D
Psychiatry
Psychiatry